GoodRx Holdings, Inc. GDRX NASDAQ

GoodRx Holdings, Inc. (GDRX) reported total assets of $1.4B and total liabilities of $787.8M for fiscal year 2025, resulting in total equity of $616.26M.

The company held $261.82M in cash and short-term investments. Total debt stood at $59.54M, with net debt of $-202.28M. The Debt-to-Equity (D/E) ratio was 0.1 (conservative).

Current ratio is 2.61, indicating strong short-term liquidity. Interest coverage is 2.5x (weak).

Criteria supported by this page:

• HEALTH (67/100, Partial) — some metrics are adequate but not all reach ideal thresholds
• MOAT (49/100) — Total assets $1.4B and equity $616.26M support the company's competitive scale
• VALUE (78/100) — Debt-to-Equity 0.1 contributes to the overall valuation risk assessment

Overall SharesGrow Score: 57/100 with 2/7 criteria passed.

GEHC

GE HealthCare Technologies Inc.

$74.67

+1.14%

VEEV

Veeva Systems Inc.

$159.09

+0.40%

DOCS

Doximity, Inc.

$22.25

-1.81%

TXG

10x Genomics, Inc.

$24.80

+5.17%

PRVA

Privia Health Group, Inc.

$23.12

+0.48%

NXGN

NextGen Healthcare, Inc.

$23.94

+0.13%

PGNY

Progyny, Inc.

$17.17

+1.12%

TDOC

Teladoc Health, Inc.

$5.24

+0.38%